Valeant Pharmaceuticals International develops and markets medications used in the fields of neurology, dermatology and infectious diseases. read more
David Silberstein — Executive Director, Regulatory Affairs at Valeant Pharmaceuticals International
Executive Bio
David Silberstein serves as the Executive Director, Regulatory Affairs of Valeant Pharmaceuticals International. David Silberstein and the Valeant Pharmaceuticals International executive team are rated a B by 6 employees.
Executive Team Culture Ratings from Valeant Pharmaceuticals International Employees
TOP
25%
Valeant Pharmaceuticals International's Executive Team scores in the Top 25%
of similar sized companies on Comparably
of similar sized companies on Comparably
Valeant Pharmaceuticals International's Executive Team at a Glance
Based on 7 ratings, Valeant Pharmaceuticals International's employees are satisfied with their Executive Team and give them a “B” or 72/100.
Valeant Pharmaceuticals International's Executive Team ranks in the Top 40% of other companies in Los Angeles and Top 25% of other companies on Comparably that also have 10,000+ Employees.
×